Structured evidence table for Lactoferrin-Skin-Health-Randomized-Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lactoferrin-Skin-Health-Randomized-Trial | They secrete cytokines and chemokines, promoting the recruitment of macrophages and polymorphs to the skin injury site, and express Toll-like receptors (TLRs), recognizing pathogen-associated molecular patterns (PAMPs). | 3 | Guryanova Svetlana V. (2026) | Lactoferrin Skin Health Randomized Trial: What the Evidence Says |
| Lactoferrin-Skin-Health-Randomized-Trial | Dermcidin helps to limit bacterial colonization on the skin during the initial hours after sweating, and therefore effectively reduces the risk of infection by pathogens encountered in the environment. | 3 | Guryanova Svetlana V. (2026) | Lactoferrin Skin Health Randomized Trial: What the Evidence Says |
| Lactoferrin-Skin-Health-Randomized-Trial | These peptides have been associated with immune regulation, anti-inflammatory, and antimicrobial properties, possibly modulating the gut microbiome and exhibiting systemic activity to mitigate microbial infections. | 4 | Kaplan Nicole (2026) | Lactoferrin Skin Health Randomized Trial: What the Evidence Says |
| Lactoferrin-Skin-Health-Randomized-Trial | In a clinical study, lactoferrin supplementation has been linked to a pronounced increase in circulating neutrophil precursors, and an associated reduction in TNF-α and IL-6 production. | 4 | Kaplan Nicole (2026) | Lactoferrin Skin Health Randomized Trial: What the Evidence Says |
Source documents